Evidence map›Paper›PMID 32209563›Full record

ArticleAntimicrobial agents and chemotherapy2020

Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"

Christine Sekaggya-Wiltshire, Maxwell Chirehwa, Joseph Musaazi, Amrei von Braun, Allan Buzibye, Daniel Muller, Ursula Gutteck, Ilaria Motta, Andrea Calcagno, Jan S Fehr and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Christine Sekaggya-WiltshireInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda csekaggya@idi.co.ug.
Maxwell ChirehwaDepartment of Pharmacology, University of Cape Town, Cape Town, South Africa.
Joseph MusaaziInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Amrei von BraunDivision of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
Allan BuzibyeInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Daniel MullerDepartment of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ursula GutteckDepartment of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ilaria MottaUnit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Andrea CalcagnoUnit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Jan S FehrDivision of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
Andrew KambuguInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Barbara CastelnuovoInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Mohammed LamordeInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Paolo DentiDepartment of Pharmacology, University of Cape Town, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32209563
PMCPMC7179258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.